Sio Gene Therapies Inc
Biotechnology
Healthcare
SIOX
72.94M shares
NASDAQ US
traded
06 Jan 2022
open
1.37
52 week high
3.44
high
1.37
52 week low
1.32
low
1.29
growth
-53.15%
previous Close
1.35
P/E ratio
-5
market cap
93.33M
div yield
0
usd
Sep 2021
qoq
revenue
net incoming
-21.24M
-78.91 %
eps
-0.29
-81.25 %
eps surprise
-66.67 %
net profit margin
-2123700000 %
operating incoming
-21.20M
-77.86 %
net change in cash
-10.47M
-30.65 %
cash on hand
102M
-8.36 %
cost of revenue
11.00K
top top